Nexalin Technology (NASDAQ: NXL) IPO warrants expire and are delisted

Rhea-AI Filing Summary

Nexalin Technology, Inc. reports that its publicly traded warrants issued as part of its initial public offering have expired. On September 22, 2025, at 5:00 PM Eastern time, these warrants, each exercisable for one share of common stock at an exercise price of $4.15, terminated in accordance with their original terms.

The Nasdaq Stock Market filed a Form 25 with the SEC to reflect that the warrants had expired and were delisted. The company’s common stock is unaffected by this change and will continue to trade on the Nasdaq Capital Market under the symbol NXL.

false 0001527352 0001527352 2025-09-22 2025-09-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 22, 2025

NEXALIN TECHNOLOGY, INC.

(Exact name of registrant as specified in its charter)

Delaware		001-41507		27-5566468
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

1776 Yorktown, Suite 550

Houston, TX 77056

Registrant’s telephone number, including area code: (832) 260-0222

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.001 per share		NXL		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01. Other Events.

On September 22, 2025, at 5:00 PM, eastern time, the warrants exercisable for one share of common stock, at an exercise price of $4.15, issued by Nexalin Technology, Inc. (the “Company”), in connection with the initial public offering that closed on September 20, 2025, expired by their terms. The Nasdaq Stock Market filed a Form 25 with the Securities and Exchange Commission to indicate that the warrants had expired and were delisted.

The common stock of the Company will continue to trade on the Nasdaq Capital Market under the symbol NXL.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit		Description
104		Cover Page Interactive File (the cover page tags are embedded within the Inline XBRL document)

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

	NEXALIN TECHNOLOGY, INC.
	By:	/s/ Mark White
		Mark White
		Chief Executive Officer
Dated: September 22, 2025

2

FAQ

What did Nexalin Technology, Inc. (NXLIW) announce in this 8-K?

Nexalin Technology, Inc. announced that its IPO warrants, each exercisable for one share of common stock at $4.15, expired on September 22, 2025, at 5:00 PM Eastern time.

What happened to Nexalin Technology’s IPO warrants?

The warrants issued in connection with Nexalin Technology’s initial public offering expired by their terms on September 22, 2025, and are no longer exercisable.

How were the expired Nexalin warrants reflected on Nasdaq and with the SEC?

The Nasdaq Stock Market filed a Form 25 with the SEC to indicate that the expired Nexalin warrants were delisted.

Does the expiration of the warrants affect Nexalin Technology’s common stock listing?

No. Nexalin Technology’s common stock will continue to trade on the Nasdaq Capital Market under the symbol NXL.

What was the exercise price of Nexalin Technology’s IPO warrants before they expired?

Each warrant was exercisable for one share of Nexalin Technology common stock at an exercise price of $4.15.

When did Nexalin Technology’s initial public offering related to these warrants close?

The initial public offering related to these warrants closed on September 20, 2025.